Cita APA (7a ed.)

SV, J., & NS, R. (2015). Should NS5A inhibitors serve as the scaffold for all-oral anti-HCV combination therapies? Dove Medical Press.

Cita Chicago Style (17a ed.)

SV, Janardhan, y Reau NS. Should NS5A Inhibitors Serve as the Scaffold for All-oral Anti-HCV Combination Therapies? Dove Medical Press, 2015.

Cita MLA (8a ed.)

SV, Janardhan, y Reau NS. Should NS5A Inhibitors Serve as the Scaffold for All-oral Anti-HCV Combination Therapies? Dove Medical Press, 2015.